| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Agios Pharmaceuticals, Inc. (AGIO) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. AGIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 149.1K | $5.23M | - | |
| Other | 67.7K | $2.38M | - | |
| CFO | 40.3K | $1.42M | - | |
| Other | 34.6K | $1.22M | - | |
| Dir | 17.8K | $624.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 9, 2023 | Foster-Cheek Kaye I | Director | Sale+OE | 25,000 | $25.96 | $648,887.50 | -68.4% | -10.8% | +68.0% | |
| Aug 8, 2023 | Goff Brian50 | Chief Executive Officer | Sale+OE | 10,178 | $25.48 | $259,335.44 | -27.7% | -13.8% | +63.7% | |
| Aug 7, 2023 | Washburn Theodore James Jr.64 | Principal Accounting Officer | Sell | 2,918 | $25.39 | $74,095.90 | -51.6% | -12.3% | +66.8% | |
| Aug 1, 2023 | Washburn Theodore James Jr.64 | Principal Accounting Officer | Sale+OE | 1,232 | $26.26 | $32,352.32 | -17.9% | -23.9% | +73.2% | |
| Jun 30, 2023 | Fouse Jacqualyn A | Director | Sale+OE | 10,718 | $28.36 | $303,962.48 | -9.1% | -12.5% | +52.3% | |
| Jun 30, 2023 | Burns James William49 | Chief Legal Officer | Sale+OE | 1,707 | $28.36 | $48,410.52 | -5.3% | -12.5% | +52.3% | |
| Jun 30, 2023 | Gheuens Sarah49 | Chief Medical Officer | Sale+OE | 1,707 | $28.36 | $48,410.52 | -6.6% | -12.5% | +52.3% | |
| Jun 30, 2023 | Goff Brian50 | Chief Executive Officer | Sale+OE | 11,449 | $28.36 | $324,693.64 | -44.8% | -12.5% | +52.3% | |
| Jun 30, 2023 | Jones Cecilia48 | Chief Financial Officer | Sale+OE | 1,597 | $28.36 | $45,290.92 | -29.7% | -12.5% | +52.3% | |
| Jun 30, 2023 | Milanova Tsveta46 | Chief Commercial Officer | Sale+OE | 1,618 | $28.36 | $45,886.48 | -29.7% | -12.5% | +52.3% |